Impact of treatment and socioeconomic status on racial disparities in survival among older women with breast cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 31, Issue 2, 2008, Pages 125-132

  Du, Xianglin L ^a   Fang, Shenying ^a   Meyer, Tamra E ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Breast cancer; Racial disparity; Socioeconomic status; Survival; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; RACE DIFFERENCE; RACISM; SOCIOECONOMICS; TUMOR VOLUME;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SOCIOECONOMIC FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 42049090877     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181587890     Document Type: Article

References (61)

1. Ries LAG, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD. Available at http://seer.cancer.gov/csr/1975_2003/. (Accessed September 7, 2006.)
2. Howe HL, Wu X, Ries LA, et al. Annual Report to the Nation on the Status of Cancer, 1975-2003, Featuring Cancer among U.S. Hispanic/Latino Populations. Cancer. 2006;107:1711-1742.
3. Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academy Press; 2002.
4. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334-357.
5. Mandelblatt JS, Kerner JF, Hadley J, et al. Variations in breast carcinoma treatment in older Medicare beneficiaries: is it black or white? Cancer. 2002;95:1401-1414.
6. Bach PB, Pham HH, Schrag D, et al. Primary care physicians who treat blacks and whites. N Engl J Med. 2004;351:575-584.
7. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78-93.
8. Krieger N, Quesenberry C Jr, Peng T, et al. Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, Black, Hispanic, and White residents of the San Francisco Bay Area, 1988-92 (United States). Cancer Causes Control. 1999;10:525-537.
9. Tammemagi CM, Nerenz David, Neslund-Dudas C, et al. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005;294:1765-1772.
10. Hershman D, McBride R, Jacobson JS, et al. Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol. 2005;23:6639-6646.
11. Field TS, Buist DS, Doubeni C, et al. Disparities and survival among breast cancer patients. J Natl Cancer Inst Monogr. 2005;(35):88-95.
12. Blackman DJ, Masi CM. Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes? J Clin Oncol. 2006;24:2170-2178.
13. Grann V, Troxel AB, Zojwalla N, Hershman D, Glied SA, Jacobson JS. Regional and racial disparities in breast cancer-specific mortality. Soc Sci Med. 2006;62:337-347.
14. Newman LA, Griffith KA, Jatoi I, et al. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol. 2006;24:1342-1349.
15. Neale AV. Racial and marital status influences on 10 year survival from breast cancer. J Clin Epidemiol. 1994;47:475-483.
16. Simon MS, Severson RK. Racial differences in survival of female breast cancer in the Detroit metropolitan area. Cancer. 1996;77:308-314.
17. Wojcik BE, Spinks MK, Optenberg SA. Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer. 1998;82:1310-1318.
18. Roetzheim RG, Gonzalez EC, Ferrante JM, et al. Effects of health insurance and race on breast carcinoma treatments and outcomes. Cancer. 2000;89:2202-2213.
19. Albain KS, Unger JM, Hutchins LF, et al. Outcome of African Americans on Southwest Oncology Group (SWOG) breast cancer adjuvant therapy trials. Presented at: 2003 San Antonio Breast Cancer Symposium, San Antonio, TX, 2003 (abstr 21).
20. Polednak AP. Survival of breast cancer patients in Connecticut in relation to socioeconomic and health care access indicators. J Urban Health. 2002;79:211-218.
21. Jatoi I, Becher H, Leake CR. Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U.S. Department of Defense Healthcare system. Cancer. 2003;98:894-899.
22. Crowe JP Jr, Patrick RJ, Rybicki LA, et al. Race is a fundamental prognostic indicator for 2325 Northeastern Ohio women with infiltrating breast cancer. Breast J. 2005;11:124-128.
23. Du W, Simon M. Racial disparities in treatment and survival of women with stage I-III breast cancer at a arge academic medical center in metropolitan Detroit. Breast Cancer Res Treat. 2005;91:243-248.
24. Perkins P, Cooksley CD, Cox JD. Breast cancer. Is ethnicity an independent prognostic factor for survival? Cancer. 1996;78:1241-1247.
25. Bassett MT, Krieger N. Social class and black-white differences in breast cancer survival. Am J Public Health. 1986;76:1400-1403.
26. Coates RJ, Clark WS, Eley JW, et al. Race, nutritional status, and survival from breast cancer. J Natl Cancer Inst. 1990;82:1684-1692.
27. Gordon NH, Crowe JP, Brumberg DJ, et al. Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol. 1992;135:609-618.
28. Ansell D, Whitman S, Lipton R, et al. Race, income, and survival from breast cancer at two public hospitals. Cancer. 1993;72:2974-2978.
29. Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer: Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994;272:947-954.
30. Franzini L, Williams AF, Franklin J, et al. Effects of race and socio-economic status on survival of 1,332 black, Hispanic, and white women with breast cancer. Ann Surg Oncol. 1997;4:111-118.
31. Howard DL, Penchansky R, Brown MB. Disaggregating the effects of race on breast cancer survival. Fam Med. 1998;30:228-235.
32. Yood MU, Johnson CC, Blount A, et al. Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst. 1999;91:1487-1491.
33. El-Tamer MB, Homel P, Wait RB. Is race a poor prognostic factor in breast cancer? J Am Coll Surg. 1999;189:41-45.
34. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94:490-496.
35. Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(8 Suppl):IV3-IV18.
36. Du XL, Chan W, Giordano S, et al. Variation in Modes of Chemotherapy Administration for Breast Carcinoma and Association with Hospitalization for Chemotherapy-related Toxicity. Cancer. 2005;104:913-924.
37. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53:1258-1267.
38. National Cancer Institute. SEER-Medicare: Calculation of Comorbidity Weights. Available at http://healthservices.cancer.gov/seermedicare/program/ comorbidity.html [accessed on July 23, 2007].
39. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
40. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
41. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46:1075-1079.
42. Du XL, Freeman JL, Warren JL, et al. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer. Med Care. 2000;38:719-727.
43. Du XL, Freeman JL, Goodwin JS. Information on radiation treatment in patients with breast cancer: the advantages of the linked Medicare and SEER data. J Clin Epidemiol. 1999;52:463-470.
44. NIH Consensus Conference. Treatment of early-stage breast cancer. JAMA. 1991;265:391-395.
45. Du XL, Key CR, Dickie L, et al. External Validation of Medicare Claims for Breast Cancer Chemotherapy Compared with Medical Chart Reviews. Med Care. 2006;44:124-131.
46. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227-1232.
47. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
48. Vinh-Hung V, Voordeckers M, Van de Steene J, et al. Omission of radiotherapy after breast-conserving surgery: survival impact and time trends. Radiother Oncol. 2003;67:147-58.
49. Vinh-Hung V, Verschraegen C. Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst. 2004;96:115-121.
50. Du XL, Gor BJ. Racial Disparities and Trends in Radiation Therapy Following Breast Conserving Surgery for Early-Stage Breast Cancer in Women from 1992 to 2002. Ethnicity Dis. 2007;17:122-128.
51. Elledge RM, Clark GM, Chamness GC, et al. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 1994;86:705-712.
52. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492-2502.
53. Li CI, Malone KE, Daling JR. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev. 2002;11:601-607.
54. Morris GJ, Naidu S, Topham AK, et al. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and end results database. Cancer. 2007 [Epub ahead of print].
55. Henson DE, Chu KC, Levine PH. Histologic grade, stage, and survival in breast carcinoma: comparison of black and white women. Cancer. 2003;98:908-917.
56. Jones BA, Kasl SV, Howe CL, et al. African American/white differences in breast carcinoma: p53 and other tumor characteristics. Cancer. 2004;101:1293-1301.
57. McCarthy EP, Burns RB, Coughlin SS, et al. Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women. Ann Intern Med. 1998;128:729-736.
58. Smith-Bindman R, Miglioretti DL, Lurie N, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006;144:541-553.
59. Sassi F, Luft HS, Guadagnoli E. Reducing racial/ethnic disparities in female breast cancer: screening rates and stage at diagnosis. Am J Public Health. 2006;96:2165-2172.
60. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet. 1998;351:1451-1467.
61. Carlson RW, Hudis CA, Pritchard KI, et al. Adjuvant endocrine therapy in hormone receptor-positive postmenopausal breast cancer: evolution of NCCN, ASCO, and St Gallen recommendations. J Natl Compr Canc Netw. 2006;4:971-979.